BMC Microbiology

Table 1 In vitro susceptibility tests of 5 clinical A. baumannii strains

From: Isolation and Characterization of a Virulent Bacteriophage AB1 of Acinetobacter baumannii

Antibiotics	MIC (μg/ml)^b
	KD311		KD312		KD331		KD332		KD334
Amoxicillin/CA^a	≥32	R	≥32	R	≥32	R	≥32	R	≥32	R
Ampicillin	≥32	R	≥32	R	≥32	R	≥32	R	≥32	R
Cefotaxime	16	I	≥64	R	16	I	16	I	16	I
Cefoxitin	≥32	R	≥32	R	≥32	R	≥32	R	≥32	R
Ceftazidime	≤8	S	≥32	R	≤8	S	≥32	R	16	I
Cephalothin	≥32	R	≥32	R	≥32	R	≥32	R	≥32	R
Gentamicin	≥16	R	1	S	≤0.5	S	2	S	≤0.5	S
Imipenem	≤4	S	≥6	R	≤4	S	≤4	S	≤4	S
Nalidixic Acid	≤16	S	≤16	S	≤16	S	≤16	S	≤16	S
Netilmicin	≤4	S	16	I	≤4	S	≤4	S	≤4	S
Nitrofurantoin	≥128	R	≥128	R	≥128	R	≥128	R	≥128	R
Pefloxacin	≤1	S	≤1	S	≤1	S	≤1	S	≤1	S
Ticarcillin	128	R	128	R	≤16	S	≥256	R	≤16	S
Tobramycin	≤0.5	S	1	S	≤0.5	S	≤0.5	S	≤0.5	S
Trimethoprim/Sulfa	≥320	R	40	S	≤10	S	80	R	≤10	S

a. clavulanic acid at a fixed concentration of 2 μg/ml.
b. R: resistant; S: susceptible; I: intermediate.

Back to article page

ISSN: 1471-2180

Contact us

General enquiries: journalsubmissions@springernature.com